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INVITED COMMENTS
Regarding “Thrombin injection for failed stent
graft repair of perforated atherosclerotic aortic
ulcer”
Enrique Criado, MD, FACS, Stony Brook, NY
The goal of embolization in the treatment of pseudoa-
neurysms is the complete thrombosis of the sac and its
eventual transformation into fibrous tissue. Transluminal
coil embolization is an established alternative form of ther-
apy for certain peripheral pseudoaneurysms but has been
only anecdotally utilized for the treatment of aortic
pseudoaneurysms.1 Incomplete thrombosis and recanaliza-
tion of the false aneurysm sac are the main shortcomings of
coil embolization, providing an uncertain risk of rupture.
Embolization with thrombin has the advantage of produc-
ing a stronger and more predictable thrombotic stimulus
than coils. Thrombin injection of arterial pseudoaneurysms
was first reported by Cope and Zeit2 in 1986 and during
recent years has become widely accepted for the treatment
of iatrogenic femoral artery pseudoaneurysms readily acces-
sible to percutaneous puncture. Several sizable institutional
experiences have suggested high efficacy in pseudoaneu-
rysm resolution and low complication rates with percuta-
neous thrombin injection3-6 and have found it a superior
alternative to ultrasound scan–guided compression in the
treatment of iatrogenic femoral pseudoaneurysms.6,7
The initial success of thrombin injection in the treat-
ment of femoral pseudoaneuryms encouraged its applica-
tion to other peripheral pathology, such as subclavian,
brachial, carotid, and visceral artery saccular aneurysms and
pseudoaneurysms. During the initial experience, the local
and systemic complications of percutaneous and translumi-
nal thrombin injection became apparent. Thrombotic ex-
tension into the treated vessel is the most common local
complication, frequently amenable to thrombectomy or
thrombolytic therapy.6 In the cerebral and visceral territo-
ries, however, such a complication is potentially devastating
and should be prevented with appropriate balloon occlu-
sion of the artery under treatment to prevent any thrombin
spillage.8 Inadvertent intravenous injection has been rare
but is recognized as a lethal complication.9 With wide-
spread exposure of the surgical population to topical bovine
thrombin for routine hemostasis, an increasing concern is
the immune response on reexposure, which can elicit an
anaphylactic reaction from the presence of preformed anti-
bovine protein immunoglobulin E antibodies10 or a severe
coagulopathy secondary to the development of factor V
plasma inhibitors.11
The experience with the use of thrombin injection for
the treatment of peripheral pseudoaneurysms prompted its
application to other, rather more complex, aortic problems.
A technically successful percutaneous transfemoral emboli-
zation of a perforated atherosclerotic aortic ulcer with coils
and thrombin was reported by Williams, Kirsh, and
Abrams12 in 1991. More recently, van den Berg et al13
reported the successful translumbar injection of thrombin
to seal a type 2 aortic endoleak, and Lin at el14 described
transluminal thrombin injection of an ascending aortic
mycotic pseudoaneurysm with immediate pseudoaneurysm
thrombosis. The latter report shows the potential intrace-
rebral propagation of thrombus, which fortunately resolved
with systemic administration of abciximab in this instance.
None of these reports provide any long-term follow-up
data, leaving us with uncertainty about the long-term out-
come.
The treatment of an aortic pseudoaneurysm arising
from a perforated thoracic aortic ulcer, which commonly
occurs in high-risk surgical candidates, is an excellent indi-
cation for the use of an endovascular graft. As in the case
reported by Feld et al in this issue of the Journal, the
proximity of the ulcer to major branches may not allow
complete coverage of the aortic orifice with an endograft,
and alternative or adjunct treatment with embolization
therapy may be advisable, if not necessary.
After failure of an endograft to seal a paraceliac aortic
ulcer, Feld and colleagues elected a translumbar approach
to inject thrombin into the pseudoaneurysm sac. It could
be argued that thrombin injection alone might have been
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sufficient to treat the pseudoaneurysm. However, we favor
the use of an endograft as the initial treatment of choice
because the results of aortic pseudoaneurysm embolization
are unknown. The authors could have conducted the em-
bolization during the endovascular grafting by translumi-
nally catheterizing the ulcer orifice, perhaps an easier pro-
cedure that may have allowed obliteration of the aortic rent
during thrombin injection to prevent luminal thrombotic
propagation. Thrombin spillage from a supraceliac injec-
tion may produce hepatic, intestinal, or renal infraction;
therefore, it should be a priority to avoid it by all means.
The prevention of spillage can be accomplished with
inflation of an aortic balloon across the aortic ulcer during
thrombin injection, which may not only prevent spillage
but also may control hemorrhage, should the pseudoaneu-
rysm rupture during the procedure. If the embolization is
done transluminally, false aneurysm injection can be done
through an over-the-wire balloon catheter inflated inside
the sac and pulled back to obliterate the neck during
injection. Hemostatic sponge may be used as a vehicle for
thrombin, in cases where a large guiding catheter or intro-
ducer sheath can be placed into the sac and the thrombin-
impregnated sponge pushed through it into the sac.
To assess the result of their procedure, Feld and col-
leagues chose to repeat a computed tomographic scan with
contrast. If we extrapolate from the current aortic endoleak
detection experience, we should wonder how sensitive com-
puted tomographic scanning is in detecting a small amount of
flow into a false aneurysm sac. For peripheral aneurysms,
duplex scan imaging is an excellent tool to monitor in real time
the results of thrombin injection. Unfortunately, external
ultrasound scan imaging is seldom possible with aortic lesions,
although it may be feasible with transesophageal ultrasound
scan or intravascular ultrasound scan. Some reports of aortic
pseudoaneurysm thrombin injection have described contrast
injection of the sac to assess the thrombotic process. This may
be a potential cause of failure because iodinated contrast may
inhibit fibrin polymerization and thereby hinder stabilization
of the thrombus.
Although the report by Feld et al suggests early success,
the authors have not documented shrinkage of the pseudo-
aneurysm, which constitutes the strongest evidence of
pseudoaneurysm resolution. We do not know what the risk
is of rupture of a thrombosed aortic pseudoaneurysm, but
we should not extrapolate from the experience with tamer
peripheral pseudoaneurysms. As it has occurred after coil
embolization, aortic pseudoaneurysms can recanalize or
continue to grow and eventually rupture as long as they
remain in continuity with the arterial lumen. The current
experience with thrombin injection of aortic pseudoaneu-
rysms is anecdotal but suggests its usefulness in dire situa-
tions.
The potentially disastrous consequences of thrombin
spillage and the uncertainty of possible rupture of a throm-
bosed aortic pseudoaneurysm should make us very cautious
in the use of thrombin. We should learn to deliver throm-
bin or other thrombotic agents in a controlled fashion with
minimal risks of spillage or systemic reaction. We should
determine the optimal concentration and dosage of the
agent for different situations. However, it will be more
difficult to anticipate the fate of thrombosed aortic
pseudoaneurysms not mechanically excluded. Until then,
sealing the neck of an aortic false aneurysm with an endo-
vascular graft or other surgical means should remain stan-
dard therapy.
The current role of thrombin injection appears appro-
priate as adjuvant therapy to improve the success in pseu-
doaneurysm resolution with endovascular grafting, or as a
bail-out technique for its technical failures. Isolated throm-
bin embolization should continue as the last resort for
those situations where endovascular or surgical grafting is
technically impossible or contraindicated or as a temporiz-
ing therapy in preparation for a definitive procedure.
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